It is a healthcare private limited company based in Hyderabad, Telangana, India, established in 2011.
2011 | Hyderabad, Telangana, India | ActiveClaro Pharmaceuticals Private Limited, a active private limited company, was established on 28 March 2011 in Hyderabad, Telangana, India. Engaging in medical & laboratory equipment within the healthcare sector, it holds CIN: U24232TG2011PTC073540. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹2.00 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Arun Singh (Additional Director), Chevuru Komaleswari (Additional Director), Chevuru Hariprasad (Director). Past directors included Srinivasa Rao Penugonda, Rafayathunnisa Sunar, Madana Mohan Reddy Ketham. Its latest AGM occurred on 31 December 2020, with the balance sheet filed on 31 March 2020. It is based at 16-2-753/1/192, Konark Towers,Flat No. 405,Gaddi Annaram, ,, Hyderabad, Telangana, 500035.
U24232TG2011PTC073540
073540
28 March 2011
₹2.00 M
₹0.10 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Claro Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Arun Singh | Additional Director | 21 Mar 2022 | Current |
| Chevuru Komaleswari | Additional Director | 09 Jan 2014 | Current |
| Chevuru Hariprasad | Director | 16 Jul 2014 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 08 Feb 2018 | Past |
| Pramod Abcsdd | Director | 21 Mar 2022 | Past |
| Pramod Abcsdd | Director | 21 Mar 2022 | Past |
| Pramod Abcsdd | Director | 02 Feb 2015 | Past |
| Pramod Abcsdd | Additional Director | 02 Feb 2015 | Past |
| Pramod Abcsdd | Director | 09 Jan 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Claro Pharmaceuticals Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 4.54% increase. The company also saw a substantial fall in profitability, with a 118.96% decrease in profit. The company's net worth dipped by a decrease of 0.62%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Claro Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Claro Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Claro Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Claro Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Arun Singh was appointed as a Additional Director was appointed as a Additional Director on 21 Mar 2022 & has been associated with this company since 3 years 9 months . was documented.
The activity Claro Pharmaceuticals Private Limited last Annual general meeting of members was held on 31 Dec 2020 as per latest MCA records. was completed.
Progress on Claro Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Hyderabad. was documented.
Progress on Chevuru Hariprasad was appointed as a Director was appointed as a Director on 16 Jul 2014 & has been associated with this company since 11 years 5 months . was documented.
The activity Chevuru Komaleswari was appointed as a Additional Director was appointed as a Additional Director on 09 Jan 2014 & has been associated with this company since 11 years 11 months . was completed.
Progress on Claro Pharmaceuticals Private Limited was registered on 28 Mar 2011 with Roc Hyderabad & aged 14 years 9 months as per MCA records. was documented.
The CIN of Claro Pharmaceuticals Private Limited is U24232TG2011PTC073540.
Claro Pharmaceuticals Private Limited is headquartered at 16-2-753/1/192, Konark Towers,Flat No. 405,Gaddi Annaram, ,, Hyderabad, Telangana, 500035.
Claro Pharmaceuticals Private Limited was incorporated on 28 March 2011.
The current directors of Claro Pharmaceuticals Private Limited are
The primary industry of Claro Pharmaceuticals Private Limited is Healthcare.
Claro Pharmaceuticals Private Limited is unlisted.
The authorized capital of Claro Pharmaceuticals Private Limited is ₹2.00 M, and the paid-up capital is ₹0.10 M.
The compliance status of Claro Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX